“showed a trend”

For BPD patients, the respective rmANOVA showed a trend toward a significant group effect between BPD patients with unresolved (disorganized) and organized attachment ( F = 3.679; df = 1; p = 0.073).

Follow-up simple tests on performance accuracy showed a trend for better performance when exposed to rhythmic as compared to arrhythmic rightward motion (F(1,24) = 3.53, p = .073, Cohen’s d = .38) and a significant advantage for arrhythmic as compared to rhythmic leftward motion (F(1,24) = 10.01, p = .004, Cohen’s d = .63).

The 1-year cumulative incidence of non-relapse mortality in the 8-day group showed a trend toward decrease compared to that in the 9-day group (4.6% vs. 21.1%, P = 0.073).

Subgroup analysis revealed that among cytogenetic high-risk patients, the CBAC group showed a trend of higher 3-year DFS (75.1% vs 52.6%, p = 0.073).

Predictors of Treatment Response Using the Exacerbation Reduction Criterion In the bivariate analysis, the variable that showed a trend towards a reduction in exacerbations was the absence of exacerbations in the previous year ( p = 0.073) ( Table S22 ).

Patients who died of melanoma after inclusion showed a trend towards more circulating MDSCs at the time of inclusion (P = 0.073).

Paired t tests on the voice and speech aspects for the prosthetic speakers in the Control and HME group, showed a trend for the prosthetic speakers to report more fluent speech with HME use ( P = 0.073).

On the contrary, beta diversity analysis showed a trend toward separation between groups at week 4 (Weighted UniFrac, p = 0.073) ( Figure 2 ).

The time × group interaction by repeated ANOVA on the improvement in depression-dejection was significant (p<0.019) and that in fatigue showed a trend (p=0.073).

A lung function based polygenic risk score was associated with annual change in %LAA-950 ( P = 4.03e-02) and with baseline measures of quantitative emphysema ( P < 1e-03) and showed a trend toward association with annual change in ALD ( P = 7.31e-02).

LBP also showed a trend towards correlating with DAS 28-3 in the subgroup of RA patients that used tobacco products ( r = 0.4599; p = 0.0731), while a moderate correlation between serum SP-D and disease duration ( r = 0.4181; p = 0.0073), as well as weak negative correlations of this biomarker with I-FABP ( r = −0.2869; p = 0.0123) and LPS ( r = −0.3287; p = 0.0411) were also noted. 3.2.

Analyses of games missed showed a trend toward offensive players missing more games than defensive players ( P = .0732).

The frequency of T-bet neg Eomes neg MAIT cells showed a trend towards a decrease during this culture (n = 9, p = 0.0732; Fig 7C ).

At later imaging sessions, this correlation no longer reached significance, but still showed a trend at 2 years after treatment, r (17) = 0.420, p = 0.0732, and 2.5 years after treatment, r (14) = 0.456, p = 0.0756.

Finally, we found a high correlation of TGFBi and POSTN levels in all pooled experiments with pooled genotypes and treatments (R 2 = 0.266, r = 0.52, p < 0.0001) ( Figure 7 E), which was significant in all genotypes except Stab2−/− , which showed a trend toward a moderate correlation (R 2 = 0.13, r = 0.36, p = 0.0734) ( Figure 7 F). 3.

Moreover, the genotypes did not differ did in terms of their variability of RTs in first test part ( p = 0.36), but showed a trend for a difference in standard deviations during the last test part ( p = 0.0734).

CD8 + T cells showed a trend towards increased numbers in the primary tumor with tilorone treatment relative to the vehicle cohort ( p = 0.0734, Supplemental Fig. 5 D), as did the number of CD69 + /CD8 + T cells compared to the doxorubicin group ( p = 0.0201) and the combination treatment group ( p = 0.08, Supplemental Fig. 5 E, F).

Similarly, patients with HER2-positive tumors showed a trend toward an increased risk compared with those with HER2-negative tumors (OR = 1.697; 95% CI, 0.951–3.029; p = 0.0734).

However, by 7 dpi, ISG15 −/− mice already showed a trend toward increased bacterial burden compared to WT mice (p = 0.0734), although the difference did not reach statistical significance ( Fig 4c ).

CD169-Cre x TLR7 fl/fl mice showed a trend of reduced VSV infection in dLN as compared to Wt mice ( p = 0.0735) although the reduction was less pronounced compared to TLR7 −/− mice ( Figure 7C ).

The ConA group showed a trend of reduced cell viability by 15.2% ( p = 0.0738).

Nonetheless, participants showed a trend for successfully upregulating based on the linear regression results (Intercept coefficient = −0.103, R 2 = 0.272 and p value = 0.0739).

In contrast, for LS BMD, ALDH2 genotype independently exerted a significant effect (P = 0.012), and the interaction between genotype and treatment duration showed a trend toward significance (P = 0.074).

Additionally, MES 0 or 1 showed a trend toward lower detection (OR, 0.14; 95% CI, 0.01-0.87; P = .074), indicating its potential relevance as a contributing factor.

Another genetic marker, TOP3B rs9610794, with a MAF of 15% in the sample set investigated, showed a trend-like association in the test set ( p = 0.074; Table 2 ) without reaching the pre-specified level of statistical significance.